Innocan Pharma CorpCanadian Securities Exchange:INNOView on OTCQB
- LAST PRICE0.2200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.2300/ 14
- Ask / Lots0.2300/ 215
- Open / Previous Close--- / 0.2200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INNO |
|---|---|---|
| 09:32 ET | 16500 | 0.2 |
| 09:33 ET | 9000 | 0.21 |
| 09:37 ET | 53500 | 0.225 |
| 09:39 ET | 1500 | 0.225 |
| 09:44 ET | 28500 | 0.225 |
| 09:46 ET | 3500 | 0.225 |
| 09:53 ET | 10000 | 0.225 |
| 09:55 ET | 6500 | 0.225 |
| 09:57 ET | 12500 | 0.225 |
| 10:00 ET | 21500 | 0.225 |
| 10:02 ET | 5000 | 0.23 |
| 10:04 ET | 13500 | 0.23 |
| 10:06 ET | 12000 | 0.23 |
| 10:08 ET | 12000 | 0.23 |
| 10:09 ET | 14000 | 0.23 |
| 10:11 ET | 19500 | 0.23 |
| 10:13 ET | 14500 | 0.23 |
| 10:15 ET | 12000 | 0.23 |
| 10:18 ET | 22500 | 0.23 |
| 10:20 ET | 8000 | 0.23 |
| 10:22 ET | 35000 | 0.235 |
| 10:24 ET | 11000 | 0.235 |
| 10:26 ET | 10000 | 0.235 |
| 10:31 ET | 4000 | 0.24 |
| 10:33 ET | 1500 | 0.235 |
| 10:36 ET | 2000 | 0.235 |
| 10:38 ET | 10500 | 0.235 |
| 10:40 ET | 2000 | 0.235 |
| 10:42 ET | 2000 | 0.235 |
| 10:44 ET | 7000 | 0.235 |
| 10:45 ET | 12000 | 0.235 |
| 10:47 ET | 7000 | 0.235 |
| 10:49 ET | 16000 | 0.235 |
| 11:02 ET | 1500 | 0.24 |
| 11:03 ET | 9000 | 0.24 |
| 11:05 ET | 14500 | 0.24 |
| 11:07 ET | 16000 | 0.23 |
| 11:09 ET | 5000 | 0.23 |
| 11:12 ET | 8500 | 0.23 |
| 11:14 ET | 46000 | 0.23 |
| 11:18 ET | 500 | 0.235 |
| 11:27 ET | 8500 | 0.24 |
| 11:30 ET | 8500 | 0.24 |
| 11:32 ET | 40500 | 0.24 |
| 11:34 ET | 3000 | 0.235 |
| 12:51 ET | 1000 | 0.23 |
| 03:30 ET | 1000 | 0.22 |
Nov 20, 2024
Press Release: Innocan Pharma Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:01PM ET on Wednesday Nov 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Innocan Pharma Corp | 62.9M | -16.2x | --- |
Biosyent Inc | 132.1M | 18.7x | +6.22% |
LSL Pharma Group Inc | 50.8M | -19.0x | --- |
Arch Biopartners Inc | 124.8M | -47.2x | --- |
1CM Inc | 29.4M | -53.0x | --- |
Medicus Pharma Ltd | 27.7M | -0.7x | --- |
Company Information
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, the Company develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan established a Joint Venture (BI Sky Global Ltd.) that focused on advanced, targeted online sales.
Contact Information
- Headquarters
- 10 Hamenofim StreetHERZLIYA, Israel 4672561
- Phone
- ---
- Fax
- ---
Executives
- Executive Chairman of the Board
- Ron Mayron
- Chief Executive Officer, Director
- Iris Bincovich
- Executive Vice President - Business Development, Director, Founder
- Yoram Drucker
- Chief Financial Officer
- Nelson Halpern
- Chief Operating Officer
- Roni Kamhi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $62.9M |
|---|---|
Revenue (TTM) | $40.4M |
Shares Outstanding | 285.7M |
Innocan Pharma Corp does not pay a dividend. | |
Beta | 2.99 |
EPS | $-0.01 |
Book Value | $0.02 |
P/E Ratio | -16.2x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4.22% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
